The Cannabis Company That Won't Mix Work With Pleasure
A limited supply of cannabis in the U.S. means those resources have to be divvied up carefully.
For Cronos Group, that means keeping its medical and recreational marijuana operations in completely different verticals, CEO Michael Gorenstein told Cheddar. That ensures patients’ needs are prioritized over those of recreational users.
“If you think about building a town, and you have a limited amount of building supplies, we want to make sure that we’re building a hospital before we’re building the bar,” he said.
Canada-based Cronos Group started trading on the NASDAQ on Tuesday, making it the first marijuana company to list on a major U.S. market.
“It’s a big milestone not just for us but for the entire industry,” said Gorenstein. “[It] just continues to show the acceptance that the cannabis industry is getting.”
And the industry does seem to be growing at break-neck speed. Arcview, a leading researcher of the cannabis market, stated in a [recent report](https://arcviewgroup.com/product/5th-edition/) that the industry brought in $9.7 billion in sales in 2017, and that number could grow to over $25 billion by 2021.
For the full interview, [click here](https://cheddar.com/videos/inside-the-first-cannabis-company-to-list-on-nasdaq).
Cheddar's Ken Buffa took the Pixel 6 Pro for a test drive, highlighting some of the new features. The latest Google smartphone comes with an upgraded camera visor that holds three cameras in place as well as Gorilla Glass Victus covering the front and back protecting against drops and scratches. The device also contains Google's first homemade processor chip called Tensor and retails for about $899.
Overstock CEO Jonathan Johnson joined Cheddar's "Opening Bell" to talk about the company's Q3 earnings beat. While supply chain issues have plagued businesses across industries, Johnson noted that the company largely avoided constraints by not pressuring suppliers to fill Overstock's own distribution centers, encouraging them to use their own. "We have a higher in-stock percentage today than we did a year ago. Not quite as high as we did pre-pandemic but better than it was last year at this time," he said.
Google notified a number of small and medium-sized customers that potential antitrust bills could have negative impacts on their own businesses. The warning appears to be an effort to drum up enough opposition to give pause to lawmakers before enacting any such legislation.
Anthony Bartolacci, VP of financials of data Sensor Tower, joined Cheddar to talk about Robinhood's massive earnings miss. He attributed part of it to the platform's exposure to cryptocurrency and its lackluster performance in Q3 following volatility. Bartolacci also noted some headwinds from a drop in engagement on the platform due to people returning to work and having less time to day trade contributing to the miss.
Pharmaceutical company Merck has announced that it will share the formula of its COVID-19 pill with poor countries free of charge. The company still intends to charge wealthier nations leaving the end cost at more than $700 per five-day treatment course.
Dems race for a deal on President Biden's economic agenda ahead of his big foreign trip. What to make of the latest threat assessment in Afghanistan. Plus, the meme cryptocurrency of the moment that's now worth more than many Fortune 500 companies.
